Fifty-three UK and 59 USA people with multiple sclerosis (MS) answered
anonymously the first questionnaire on cannabis use and MS, From 97 t
o 30% of the subjects reported cannabis improved (in descending rank o
rder): spasticity, chronic pain of extremities, acute paroxysmal pheno
menon, tremor, emotional dysfunction, anorexia/weight loss, fatigue st
ates, double vision, sexual dysfunction, bowel and bladder dysfunction
s, vision dimness, dysfunctions of walking and balance, and memory los
s. The MS subjects surveyed have specific therapeutic reasons for smok
ing cannabis. The survey findings will aid in the design of a clinical
trial of cannabis or cannabinoid administration to MS patients or to
other patients with similar signs or symptoms.